Main Menu
Print PDF

Funding Models — Strategies to Access Capital and Pave a Runway for Commercial Success

CBI's Finance & Accounting for Bioscience Companies (Cambridge, MA) | September 24, 2019

Corporate and Securities Chair Ryan Udell will moderate the panel discussion, "Funding Models — Strategies to Access Capital and Pave a Runway for Commercial Success," at the 3rd Annual Finance & Accounting for Bioscience Companies presented by CBI on September 24, 2019 in Cambridge, MA. Joining Ryan on the panel are:

  • Shane Kovacs, Chief Business and Financial Officer, BlueRock Therapeutics
  • Howard Horn, Chief Financial Officer, VIR Biotechnology
  • Mark Levin, Co-Founder, Third Rock Ventures

The Conference convenes nearly 200 senior-level executives and hones in on the unique challenges face by small- and mid-sized biotech and pharmaceutical companies as they transition from private to public, enter into collaborations, cultivate talent and recognize revenue.

White and Williams is proud to be a Executive sponsor of the Conference. For more information and to register, please visit CBI's Conference website.

Back to Page